| MicroRNAs in body fluids—the mix of hormones and biomarkers MA Cortez, C Bueso-Ramos, J Ferdin, G Lopez-Berestein, AK Sood, ... Nature reviews Clinical oncology 8 (8), 467-477, 2011 | 1762 | 2011 |
| Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression L Chen, DL Gibbons, S Goswami, MA Cortez, YH Ahn, LA Byers, X Zhang, ... Nature communications 5 (1), 5241, 2014 | 976 | 2014 |
| Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic … F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, ... Cancer discovery 5 (8), 860-877, 2015 | 865 | 2015 |
| PDL1 Regulation by p53 via miR-34 MA Cortez, C Ivan, D Valdecanas, X Wang, HJ Peltier, Y Ye, L Araujo, ... Journal of the National Cancer Institute 108 (1), djv303, 2016 | 668 | 2016 |
| MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases MA Cortez, GA Calin Expert opinion on biological therapy 9 (6), 703-711, 2009 | 569 | 2009 |
| Combining radiation and immunotherapy: a new systemic therapy for solid tumors? C Tang, X Wang, H Soh, S Seyedin, MA Cortez, S Krishnan, E Massarelli, ... Cancer immunology research 2 (9), 831-838, 2014 | 337 | 2014 |
| MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer R Bhattacharya, M Nicoloso, R Arvizo, E Wang, A Cortez, S Rossi, ... Cancer research 69 (23), 9090-9095, 2009 | 306 | 2009 |
| Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy X Wang, JE Schoenhals, A Li, DR Valdecanas, H Ye, F Zang, C Tang, ... Cancer research 77 (4), 839-850, 2017 | 239 | 2017 |
| Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia DA Moreno, CA Scrideli, MAA Cortez, R de Paula Queiroz, ET Valera, ... British journal of haematology 150 (6), 665-673, 2010 | 237 | 2010 |
| Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time … CA Scrideli, CG Carlotti, OK Okamoto, VS Andrade, MAA Cortez, ... Journal of neuro-oncology 88, 281-291, 2008 | 230 | 2008 |
| Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer MA Cortez, D Valdecanas, X Zhang, Y Zhan, V Bhardwaj, GA Calin, ... Molecular Therapy 22 (8), 1494-1503, 2014 | 226 | 2014 |
| Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas AKB Lucio-Eterovic, MAA Cortez, ET Valera, FJN Motta, RGP Queiroz, ... BMC cancer 8, 1-10, 2008 | 224 | 2008 |
| Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. Cancer Discov … F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, ... DOI: https://doi. org/10.1158/2159-8290. CD-14-1236, 860-877, 2015 | 188 | 2015 |
| miR‐29b and miR‐125a regulate podoplanin and suppress invasion in glioblastoma MA Cortez, MS Nicoloso, M Shimizu, S Rossi, G Gopisetty, JR Molina, ... Genes, Chromosomes and Cancer 49 (11), 981-990, 2010 | 176 | 2010 |
| Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma HB Barsoumian, R Ramapriyan, AI Younes, MS Caetano, H Menon, ... Journal for immunotherapy of cancer 8 (2), e000537, 2020 | 170 | 2020 |
| Role of miRNAs in immune responses and immunotherapy in cancer MA Cortez, S Anfossi, R Ramapriyan, H Menon, SC Atalar, M Aliru, ... Genes, Chromosomes and Cancer 58 (4), 244-253, 2019 | 152 | 2019 |
| Altered cancer metabolism in mechanisms of immunotherapy resistance R Ramapriyan, MS Caetano, HB Barsoumian, ACP Mafra, EP Zambalde, ... Pharmacology & therapeutics 195, 162-171, 2019 | 149 | 2019 |
| Role of radiation therapy in modulation of the tumor stroma and microenvironment H Menon, R Ramapriyan, TR Cushman, V Verma, HH Kim, ... Frontiers in immunology 10, 193, 2019 | 149 | 2019 |
| Phase II trial of ipilimumab with stereotactic radiation therapy for metastatic disease: outcomes, toxicities, and low-dose radiation–related abscopal responses JW Welsh, C Tang, P De Groot, A Naing, KR Hess, JV Heymach, ... Cancer immunology research 7 (12), 1903-1909, 2019 | 124 | 2019 |
| Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy H Menon, D Chen, R Ramapriyan, V Verma, HB Barsoumian, ... Journal for immunotherapy of cancer 7, 1-9, 2019 | 121 | 2019 |
